FDA
approval
· 2025-12-09
FDA Approved: SUMATRIPTAN — Supplemental Application (Prasco Laboratories)
Summary
FDA approved a supplemental application for Sumatriptan submitted by Prasco Laboratories.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for SUMATRIPTAN (SUMATRIPTAN)